INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
SEC FORM 4/Grant or awardVerified data

Befidi Robert reported NVST

President, Diagnostics · Envista Holdings Corp · Envista Holdings Corp — Envista deferred contribution programs - Envista Stock Fund

Side
A
Value
$23K
Shares
998
Price
$23.47
Executed
Feb 1, 2026
Disclosed
Feb 3, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Feb 1 executedFeb 3, 2026 disclosed

NVST · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
21/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+13 / 25

$23K reported value · 86.7% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · NVST

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    16
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$141K
    5,147 sh
    		Aug 25, 2026Aug 27, 2026
    traded Aug 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$22K
    804 sh
    		Aug 25, 2026Aug 27, 2026
    traded Aug 25, 2026
    		+2dSEC FORM 4

    Evidence

    16
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$212K
    7,710 sh
    		Aug 25, 2026Aug 27, 2026
    traded Aug 25, 2026
    		+2dSEC FORM 4

    Evidence

    16
    RM
    Reis MischaSVP, Strategy & Bus. Dev.
    NVSTEnvista Holdings Corp
    Open-market sale · 10b5-1 plan
    		SELL$220K
    8,000 sh
    		Aug 20, 2026Aug 24, 2026
    traded Aug 20, 2026
    		+4dSEC FORM 4

    Evidence

    13
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    7,605 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    18.0K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    13.8K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$5,385
    182 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    13.8K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    16
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$64K
    2,177 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    13.8K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    18.0K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    16
    KC
    Kaabi Faez CChief Accounting Officer
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$147K
    4,964 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    17
    KC
    Kaabi Faez CChief Accounting Officer
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    13.5K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    18.0K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$42K
    1,412 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    13
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    7,605 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    13
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    7,605 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Grant or award
    		A$23K
    998 sh
    		Feb 1, 2026Feb 3, 2026
    traded Feb 1, 2026
    		+2dSEC FORM 4

    Evidence

    17
    KC
    Kaabi Faez CChief Accounting Officer
    NVSTEnvista Holdings Corp
    Grant or award
    		A$28K
    1,186 sh
    		Feb 1, 2026Feb 3, 2026
    traded Feb 1, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002012361-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Feb 1, 2026
    Published
    Feb 3, 2026
    Ingested by INSIDER
    Nov 5, 04:19 UTC
    Last re-read
    Nov 5, 04:19 UTC

    Extracted facts

    Filer
    Befidi Robert
    Role
    President, Diagnostics
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Envista Holdings Corp — Envista deferred contribution programs - Envista Stock Fund
    Ticker
    NVST
    Shares
    998
    Price per share
    $23.47
    Value
    $23,423
    Execution date (reported)
    Feb 1, 2026
    Owned after transaction
    2,149 shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 998
    • Price: $23.47

    = $23,423

    What this establishes

    Befidi Robert filed this Form 4 reporting a grant or award of NVST on Feb 1, 2026. It became public on Feb 3, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    President, Diagnostics
    Befidi Robertcik:0002012361
    Issuer
    Envista Holdings Corpcik:0001757073

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.